B
BioMaxima SA
WSE:BMX
BioMaxima SA
WSE:BMX
Price:
11.4
PLN
-2.98%
Market Cap:
zł47.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
BioMaxima SA
WSE:BMX
|
PL |
|
M
|
Mytilineos SA
ATHEX:MYTIL
|
GR |
|
S
|
SinoCloud Group Ltd
SGX:5EK
|
HK |
|
Dixon Technologies (India) Ltd
BSE:540699
|
IN |
|
Genting Malaysia Bhd
OTC:GMALF
|
MY |
|
Jefferies Financial Group Inc
NYSE:JEF
|
US |
Balance Sheet
Balance Sheet Decomposition
BioMaxima SA
BioMaxima SA
Balance Sheet Decomposition is not available for
BioMaxima SA
BioMaxima SA
Balance Sheet
BioMaxima SA
BioMaxima SA
Currency: PLN
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
1
|
1
|
4
|
3
|
2
|
1
|
|
| Cash |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
2
|
1
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
4
|
3
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
5
|
5
|
5
|
6
|
6
|
9
|
17
|
9
|
11
|
|
| Accounts Receivables |
4
|
5
|
5
|
5
|
6
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
6
|
8
|
9
|
10
|
9
|
12
|
14
|
13
|
14
|
|
| Other Current Assets |
1
|
1
|
2
|
1
|
3
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
13
|
15
|
18
|
18
|
18
|
25
|
34
|
23
|
25
|
|
| PP&E Net |
6
|
7
|
8
|
24
|
23
|
22
|
28
|
51
|
51
|
|
| Intangible Assets |
2
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
22
N/A
|
25
+13%
|
27
+10%
|
44
+61%
|
43
-2%
|
48
+10%
|
62
+30%
|
74
+19%
|
76
+3%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
2
|
3
|
4
|
6
|
5
|
8
|
7
|
5
|
7
|
|
| Accrued Liabilities |
0
|
0
|
1
|
5
|
9
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
4
|
8
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
3
|
3
|
8
|
6
|
1
|
1
|
4
|
9
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
|
| Total Current Liabilities |
3
|
7
|
8
|
19
|
20
|
13
|
17
|
10
|
17
|
|
| Long-Term Debt |
4
|
1
|
2
|
7
|
6
|
8
|
9
|
9
|
6
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
7
|
6
|
7
|
6
|
|
| Total Liabilities |
6
N/A
|
8
+27%
|
10
+25%
|
27
+172%
|
27
-1%
|
28
+3%
|
33
+18%
|
27
-18%
|
29
+8%
|
|
| Equity | ||||||||||
| Common Stock |
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Retained Earnings |
12
|
12
|
13
|
12
|
12
|
6
|
15
|
33
|
33
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
10
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
1
|
1
|
1
|
1
|
10
|
10
|
10
|
0
|
|
| Total Equity |
16
N/A
|
17
+7%
|
17
+3%
|
17
-3%
|
16
-2%
|
20
+21%
|
29
+47%
|
47
+61%
|
47
+1%
|
|
| Total Liabilities & Equity |
22
N/A
|
25
+13%
|
27
+10%
|
44
+61%
|
43
-2%
|
48
+10%
|
62
+30%
|
74
+19%
|
76
+3%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
|
Switch to:
Switch to:
See Also
Discover More
